Technical Analysis for HROW - Harrow Health, Inc.

Grade Last Price % Change Price Change
D 10.49 0.00% 0.00
HROW closed unchanged on Monday, March 18, 2024, on 1.24 times normal volume. It was able to find support at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Mar 21
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Flat Down

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Inside Day Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Crossed Above 50 DMA Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish 3.05%
MACD Bearish Centerline Cross Bearish 3.05%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 14 hours ago
60 Minute Opening Range Breakdown about 15 hours ago
Down 2 % about 15 hours ago
60 Minute Opening Range Breakout about 16 hours ago
50 DMA Support about 17 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Harrow Health, Inc. Description

Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. The Company owns, markets and dispenses a portfolio of compounded therapeutic in several therapeutic areas, including ophthalmology, urology, otolaryngology and infectious diseases. The Company is also developing Custom Compounding Choice business, which is focused on developing and dispensing a portfolio of non-proprietary compounded drugs for humans and animals in therapeutic areas that may be overlooked by commercial pharmaceutical companies. The Company also offers customizable compounding products that consist of sterile injectable and non-sterile integrative medicine therapies that are used in various therapeutic areas.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Pharmacy Infectious Diseases Ophthalmology Urology Pharmaceutical Sciences Drug Therapies Compounding

Is HROW a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 28.25
52 Week Low 7.6
Average Volume 336,906
200-Day Moving Average 14.05
50-Day Moving Average 10.44
20-Day Moving Average 10.95
10-Day Moving Average 10.75
Average True Range 0.56
RSI (14) 46.52
ADX 17.14
+DI 20.96
-DI 20.48
Chandelier Exit (Long, 3 ATRs) 10.46
Chandelier Exit (Short, 3 ATRs) 11.75
Upper Bollinger Bands 11.72
Lower Bollinger Band 10.18
Percent B (%b) 0.2
BandWidth 14.10
MACD Line -0.04
MACD Signal Line 0.07
MACD Histogram -0.1153
Fundamentals Value
Market Cap 368.38 Million
Num Shares 35.1 Million
EPS -0.44
Price-to-Earnings (P/E) Ratio -23.84
Price-to-Sales 3.32
Price-to-Book 5.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.94
Resistance 3 (R3) 10.90 10.71 10.87
Resistance 2 (R2) 10.71 10.60 10.73 10.84
Resistance 1 (R1) 10.60 10.52 10.66 10.64 10.81
Pivot Point 10.41 10.41 10.44 10.43 10.41
Support 1 (S1) 10.30 10.30 10.36 10.34 10.17
Support 2 (S2) 10.11 10.22 10.13 10.14
Support 3 (S3) 10.00 10.11 10.12
Support 4 (S4) 10.04